OakChart

Vivani Medical Inc

VANIHealthcare·Biotechnology·USA·Micro·NASD·Nov 11 • 3:59 PM ET

1.13-0.02 (-1.74%)
2026-11-12 00:42 CET
Market cap
103.73 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-26.31 USD m
Free cash flow, TTM
-26.50 USD m
EPS diluted, TTM
-0.36
P/E
-
Compare

Price

VANI against its 20, 50 and 200-day averages
2050200beatearnings
1.001.201.401.605.8M11.6MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26VANIclose 1.1320-day 1.1150-day 1.20200-day 1.241.1352w high

32.0% under the 52-week high of 1.66 on 9 Jul 2026. 52-week low 0.92 on 30 Mar 2026. Last 15 sessions, 18.8% high to low

Volume 0.67× normal · the line is the 50-bar volume average

Profile

VANI
52-week range, 28% of the way up
0.921.66

Vivani Medical, Inc. is a preclinical stage biopharmaceutical company, which engages in the business of developing miniaturized, subdermal implants utilizing proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases. It operates under the Biopharm Division and Neuromodulation Division segments. The company was founded by Adam Mendelsohn on May 22, 2003 and is headquartered in Alameda, CA.

Employees42
IPONov 19, 2014
Beta2.46
ATR, 14d0.06
Rel volume0.67
Short float0.98%
Insider own58.05%
Inst own5.66%

Snapshot

6 groups

Valuation

Index-
Market Cap101.93M
Enterprise Value99.93M
Income-26.31M
Sales0.00M
Book/sh0.21
Cash/sh0.22
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees42
IPONov 19, 2014

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B5.33
P/C5.12
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio3.25
Current Ratio3.25
Debt/Eq0.94
LT Debt/Eq0.84
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.36
EPS next Y-0.46
EPS next Q-
EPS this Y23.26%
EPS next Y-37.88%
EPS next 5Y2.38%
EPS past 3/5Y-5.50% 27.77%
Sales past 3/5Y- -
EPS Y/Y TTM19.38%
Sales Y/Y TTM-
EPS Q/Q39.39%
Sales Q/Q-
EarningsNov 11 AMC
EPS/Sales Surpr.15.97% -

Ownership

Insider Own58.05%
Insider Trans8.20%
Inst Own5.66%
Inst Trans-3.31%
ROA-74.60%
ROE-220.40%
ROIC-75.22%
Gross Margin-
Oper. Margin-
Profit Margin-
SMA201.64%
SMA50-5.76%
SMA200-9.21%
Trades-

Technical

Shs Outstand89.41M
Shs Float37.84M
Short Float0.98%
Short Ratio1.82
Short Interest0.37M
52W High1.66 -31.96%
52W Low0.92 22.46%
Volatility6.15% 5.33%
ATR (14)0.06
RSI (14)48.56
Beta2.46
Rel Volume0.67
Avg Volume203.21K
Volume136,617

Performance

Perf Week5.61%
Perf Month-4.24%
Perf Quarter-15.67%
Perf Half Y-2.59%
Perf YTD-8.13%
Perf Year-20.98%
Perf 3Y18.70%
Perf 5Y-85.95%
Perf 10Y-97.82%
Recom1.00
Target Price4.00
Prev Close1.15
Price1.13
Change %-1.74%

Peers

Mkt cap
TickerCompanyMkt cap
RANIRani Therapeutics Holdings Inc79.18M
AARDAardvark Therapeutics Inc34.79M
CRBPCorbus Pharmaceuticals Holdings Inc77.36M
VKTXViking Therapeutics Inc3.63B
ALTAltimmune Inc375.41M
OCULOcular Therapeutix Inc1.47B
BMEABiomea Fusion Inc44.28M
NVONovo Nordisk ADR137.48B
SKYESkye Bioscience Inc4.06M
LPCNLipocine Inc17.61M

Insider trading

11 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Williams GreggDirectorJul 15 '26Buy1.26793,650999,99936,912,736Jul 16 09:00 AM
Williams GreggDirectorJun 15 '26Buy1.261,587,3011,999,99936,119,086Jun 16 09:00 AM
Williams GreggDirectorMay 15 '26Buy1.261,587,3011,999,99934,531,785May 19 08:31 AM
Williams GreggDirectorApr 15 '26Buy1.261,587,3011,999,99932,944,484Apr 16 06:30 AM
Williams GreggDirectorMar 15 '26Buy1.071,575,2311,683,33531,357,183Mar 16 06:15 AM
Williams GreggDirectorFeb 15 '26Buy1.061,866,4921,983,33329,781,952Feb 17 06:01 AM
Williams GreggDirectorJan 27 '26Buy1.481,351,3511,999,99927,915,460Jan 28 10:01 AM
Williams GreggDirectorJan 15 '26Buy1.141,737,7651,983,33426,564,109Jan 20 09:00 AM
Mendelsohn AaronDirectorDec 29 '25Buy1.2320,00024,600188,170Dec 31 09:00 AM
Williams GreggDirectorDec 15 '25Buy1.141,737,7651,983,33424,826,344Dec 16 09:00 AM
Williams GreggDirectorNov 15 '25Buy1.141,737,7641,983,33323,088,579Nov 17 09:00 AM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWCiShares Micro-Cap ETFAUM: 1.22B

News

latest 14 of 100

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-11--0.090--0.002
2026Q22026-08-13-0.070-0.083-0.0700.000.003
2026Q12026-05-13-0.080-0.080-0.0830.000.002
2025Q42026-03-26-0.090-0.090-0.0900.000.002
2025Q32025-11-13-0.110-0.110-0.1090.000.002
2025Q22025-08-13-0.120-0.100-0.1210.000.002
2025Q12025-05-13-0.110-0.105-0.1060.000.002
2024Q42025-03-31-0.110-0.110-0.1050.000.002
2024Q32024-11-13-0.110-0.105-0.1090.000.002
2024Q22024-08-13-0.100-0.120-0.0970.00-1
2024Q12024-05-13-0.120-0.120-0.1160.50-1
2023Q42024-03-26-0.120-0.140-0.118--1
2023Q32023-11-14-0.130-0.130-0.133--1
2023Q22023-08-14-0.130-0.110-0.129--1
2023Q12023-05-15-0.120--0.125---
2022Q32022-11-14--0.037---

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2017FY-12.240-11.040-12.7207.966.80
2018FY-11.040-11.520-12.6896.907.76
2019FY-5.730-6.660-6.8523.383.35
2022FY-0.360-0.260-0.363--
2023FY-0.500-0.530-0.5043.38-
2024FY-0.430-0.423-0.4270.000.00
2025FY-0.430-0.417-0.4300.000.00
2026FY--0.330--0.00
2027FY--0.455--0.00
2028FY--0.400---
2029FY--0.430---
2030FY--0.360---

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-10-161000.000.000.00
2026Q3S2026-08-142000.000.000.00
2026Q3S2026-08-132000.000.000.00
2026Q3S2026-06-222000.000.000.00
2026Q3S2026-05-141000.000.000.00
2026Q3S2026-03-301000.000.000.00
2026Q3S2025-11-131000.000.000.00
2026Q3S2025-11-111000.000.000.00
2026Q3S2025-11-101000.000.000.00
2026Q3S2025-11-091000.000.000.00
2026Q3S2025-11-081000.000.000.00
2026Q3S2025-11-071000.000.000.00
2026Q3S2025-11-061000.000.000.00
2026Q3S2025-11-051000.000.000.00

Estimate history

EPS, annual-12.72-12.689-6.852-2.17-1.158-0.363-0.504-0.427-0.427-0.3561
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.097-0.109-0.105-0.106-0.121-0.109-0.09-0.083-0.073
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual7.9646.8963.3790000000
Period201720182019202020212022202320242025TTM
Sales, quarterly000000000
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual2.4013.1815.2147.73812.26850.73651.03159.23576.42889.41
Period201720182019202020212022202320242025MRQ
Shares, quarterly55.19755.26659.23559.24459.24461.51176.42884.64889.41
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue0.000.000.000.000.000.000.003.386.90
Cost of Goods Sold Incl. D&A0.480.420.400.360.380.340.172.154.89
Gross Profit-0.48-0.42-0.40-0.36-0.38-0.34-0.171.232.01
Selling, General and Administrative Excl. Other26.7527.1324.2826.6120.1612.9813.0031.8236.83
Research and Development17.6217.7015.7416.9714.1711.006.5216.5010.21
Other Operating Expense0.000.000.000.000.000.00-0.500.000.00
Operating Income-27.23-27.56-24.68-26.96-20.54-13.32-12.67-30.60-34.83
Interest Expense---0.000.000.00--0.00
Unusual Expense0.000.000.000.000.700.002.233.360.56
Net Income Before Taxes-26.31-26.61-23.49-25.65-13.89-12.77-14.88-33.59-35.09
Income Taxes0.000.000.000.000.000.000.000.000.00
Consolidated Net Income-26.31-26.61-23.49-25.65-13.89-12.77-14.88-33.59-35.09
Net Income From Continuing Operations-26.31-26.61-23.49-25.65-13.89-12.77-14.88-33.59-35.09
Net Income-26.31-26.61-23.49-25.65-13.89-12.77-14.88-33.59-35.09
EPS (Recurring)-0.30-0.43-0.43-0.50-0.35-1.16-1.94-6.37-12.55
EPS (Basic, Before Extraordinaries)-0.36-0.43-0.43-0.50-0.36-1.16-2.17-6.85-12.69
EPS (Diluted)-0.36-0.43-0.43-0.50-0.36-1.16-2.17-6.85-12.69
EBITDA-26.75-27.13-24.28-26.61-20.16-12.98-12.50-30.18-34.39
Non-Operating Income (Expense)0.910.951.191.317.350.550.020.360.29
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.371.481.611.861.301.670.422.923.59
Price To Sales Ratio-------25.848.52
Gross Margin-------36.3129.12
Operating Margin--------905.50-505.00
Net Margin--------994.14-508.90
Shares Outstanding89.4176.4359.2351.0350.7412.277.745.213.18
Market Capitalization103.73103.7368.7152.0543.1164.2443.4192.8667.60

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.130.130.120.100.100.100.090.11
Gross Profit-0.13-0.13-0.12-0.10-0.10-0.10-0.09-0.11
Selling, General and Administrative Excl. Other6.756.696.706.627.366.466.376.20
Research and Development4.334.264.514.524.764.224.304.20
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-6.87-6.82-6.81-6.72-7.46-6.56-6.46-6.31
Interest Expense----0.00---
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-6.37-6.78-6.63-6.53-7.14-6.30-6.05-6.04
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-6.37-6.78-6.63-6.53-7.14-6.30-6.05-6.04
Net Income From Continuing Operations-6.37-6.78-6.63-6.53-7.14-6.30-6.05-6.04
Net Income-6.37-6.78-6.63-6.53-7.14-6.30-6.05-6.04
EPS (Recurring)-0.07-0.08-0.09-0.11-0.12-0.11-0.11-0.11
EPS (Basic, Before Extraordinaries)-0.07-0.08-0.09-0.11-0.12-0.11-0.11-0.11
EPS (Diluted)-0.07-0.08-0.09-0.11-0.12-0.11-0.11-0.11
EBITDA-6.75-6.69-6.70-6.62-7.36-6.46-6.37-6.20
Non-Operating Income (Expense)0.500.040.180.200.320.260.410.27
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.310.310.470.280.390.350.400.47
Shares Outstanding89.4184.6576.4361.5159.2459.2459.2355.27
Market Capitalization103.7384.6589.7383.5376.4262.2068.7164.65

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments16.2318.3520.6545.082.183.1811.334.477.84
Short Term Receivables0.650.250.000.000.000.000.460.501.83
Inventories0.000.000.000.000.000.001.033.252.70
Other Current Assets1.011.842.412.450.291.090.301.400.80
Total Current Assets17.9020.4423.0647.532.474.2713.119.6213.16
Net Property, Plant & Equipment20.1119.6521.341.962.780.173.461.021.30
Total Investments and Advances1.341.341.341.370.000.000.000.000.00
Long-Term Note Receivable--------0.00
Intangible Assets--------0.00
Deferred Tax Assets2.14--------
Other Assets0.050.130.050.280.200.020.030.040.03
Total Assets41.5341.5645.8051.135.454.4616.6010.6814.50
Short Term Debt Incl. Current Port. of LT Debt2.041.581.380.950.912.200.240.000.00
Accounts Payable1.030.000.000.000.000.491.091.300.75
Other Current Liabilities3.534.404.345.871.182.455.636.295.86
Total Current Liabilities6.605.995.726.822.095.136.967.606.62
Long Term Debt17.0617.9619.310.000.900.002.370.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities2.14--------
Other Liabilities0.000.000.000.000.000.000.000.000.00
Total Liabilities25.8023.9525.046.822.995.139.327.606.62
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity15.7317.6120.7644.312.46-0.677.283.087.88
Total Shareholders Equity15.7317.6120.7644.312.46-0.677.283.087.88
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity15.7317.6120.7644.312.46-0.677.283.087.88
Total Liabilities & Stockholders Equity41.5341.5645.8051.135.454.4616.6010.6814.50
Book Value Per Share0.210.300.410.870.20-0.091.400.973.28
Tangible Book Value Per Share0.210.300.410.870.20-0.091.400.973.28
Full-Time Employees424244501512112123112
Price to Book Ratio5.423.501.990.840.94-64.6012.7621.928.36
Return on Assets-64.05-53.77-52.93-22.77-257.70-141.32-246.27-278.76-182.16
Return on Equity-159.62-122.42-78.85-24.65-1,424.76-450.70-648.56-640.05-299.66
Return on Invested Capital-81.15-66.02-64.01-31.35-379.36--348.46-1,137.94-361.79
Quick Ratio2.713.414.036.971.180.831.740.841.58
Current Ratio2.713.414.036.971.180.831.881.271.99

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-26.31-26.61-23.49-25.65-13.89-12.77-14.88-33.59-35.09
Depreciation0.480.420.400.360.380.340.170.410.43
Other Funds (Non Cash)1.131.641.952.89-5.621.041.645.514.42
Funds from Operations-24.70-24.55-21.14-22.41-19.12-11.39-13.08-27.67-30.23
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-0.600.230.35-1.290.340.44-3.740.040.42
Cash from Operating Activities-25.30-24.32-20.79-23.70-18.79-10.95-16.82-27.63-29.81
Capital Expenditures-1.20-1.17-0.56-0.89-0.34-0.57-0.33-0.49-0.16
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00-
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.400.00-
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-1.20-1.17-0.56-0.89-0.34-0.570.07-0.49-0.16
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock39.0523.2618.820.130.0211.626.4034.9926.60
Repurchase of Common Pref Stock0.000.000.000.000.000.00-0.280.000.00
Sale of Common Pref Stock39.0523.2618.820.130.0211.626.6834.9926.60
Proceedsfrom Stock Options16.9214.725.130.130.0211.626.6834.5125.94
Issuance or Reduction of Debt, Net0.040.010.240.008.000.000.000.000.00
Change in Long Term Debt0.000.000.000.008.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.008.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.0055.370.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities39.0923.2719.050.1363.3911.628.6034.9926.60
Exchange Rate Effect0.070.10-0.010.00-0.000.000.01-0.010.00
Net Change in Cash12.65-2.12-2.30-24.4544.260.10-8.156.86-3.37
Free Cash Flow-26.50-25.49-21.34-24.59-19.12-11.52-17.15-28.12-29.97
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments19.8919.7516.232.636.7913.01
Short Term Receivables0.710.700.650.660.490.17
Inventories0.000.000.000.000.000.00
Other Current Assets1.031.101.010.881.431.67
Total Current Assets21.6421.5517.904.178.7114.85
Net Property, Plant & Equipment19.0219.3720.1119.5118.7219.13
Total Investments and Advances0.891.341.341.341.341.34
Deferred Tax Assets--2.14---
Other Assets0.090.100.050.020.130.13
Total Assets41.6442.3541.5325.0528.9135.45
Short Term Debt Incl. Current Port. of LT Debt1.881.922.041.391.341.41
Accounts Payable1.201.471.031.431.760.00
Other Current Liabilities3.583.393.534.013.624.79
Total Current Liabilities6.666.786.606.836.726.20
Long Term Debt16.0116.4917.0616.9117.2817.63
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities--2.14---
Other Liabilities0.000.000.000.000.000.00
Total Liabilities22.6723.2725.8023.7424.0023.83
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity18.9719.0915.731.314.9111.62
Total Shareholders Equity18.9719.0915.731.314.9111.62
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity18.9719.0915.731.314.9111.62
Total Liabilities & Stockholders Equity41.6442.3541.5325.0528.9135.45
Book Value Per Share0.210.230.210.020.080.20
Tangible Book Value Per Share0.210.230.210.020.080.20
Full-Time Employees--42---
Price to Book Ratio5.424.8657.8017.016.573.53
Return on Assets-74.60-69.63-64.05-76.61-66.22-53.23
Return on Equity-220.40-176.41-159.62-265.02-177.75-117.76
Return on Invested Capital-18.21-19.06-20.23-35.85-32.20-21.54
Quick Ratio3.253.182.710.611.302.40
Current Ratio3.253.182.710.611.302.40

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-6.37-6.78-6.63-6.53-7.14-6.30
Depreciation0.130.130.120.100.100.10
Other Funds (Non Cash)0.010.350.470.320.440.41
Funds from Operations-6.24-6.30-6.05-6.11-6.60-5.79
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.200.11-0.67-0.240.510.63
Cash from Operating Activities-6.04-6.20-6.72-6.35-6.09-5.16
Capital Expenditures-0.10-0.00-0.27-0.82-0.07-0.01
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.10-0.00-0.27-0.82-0.07-0.01
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock5.949.8220.702.590.00-0.03
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock5.949.8220.702.590.00-0.03
Proceedsfrom Stock Options0.002.1714.750.000.00-0.03
Issuance or Reduction of Debt, Net-0.11-0.11-0.110.35-0.10-0.14
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities5.839.7120.592.95-0.10-0.17
Exchange Rate Effect0.000.000.010.060.04-0.01
Net Change in Cash-0.303.5213.60-4.17-6.21-5.34
Free Cash Flow-6.13-6.20-6.99-7.17-6.16-5.17

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.98%0.4M37.8M192.10K
2026-10-151.10%0.4M37.8M203.51K
2026-09-301.37%0.5M37.8M475.82K
2026-09-151.83%0.7M37.8M477.63K
2026-08-311.40%0.5M35.4M453.67K
2026-08-141.50%0.5M35.4M457.25K
2026-07-311.47%0.5M33.9M462.78K
2026-07-151.05%0.4M33.9M508.14K
2026-06-301.25%0.4M34.7M226.41K
2026-06-151.09%0.4M34.7M242.46K
2026-05-290.84%0.3M40.2M248.50K
2026-05-150.98%0.4M40.2M247.21K
2026-04-300.97%0.4M36.3M272.27K
2026-04-151.46%0.5M36.2M320.93K
2026-03-311.66%0.5M32.2M314.65K
2026-03-131.16%0.3M27.7M311.00K
2026-02-271.05%0.3M27.7M302.49K
2026-02-131.41%0.4M27.7M301.24K
2026-01-301.30%0.4M30.9M297.65K
2026-01-150.69%0.2M30.9M302.05K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call1.000.000.300.203.5076450.000.697-0.0080.001
call2.000.000.050.013.2841,4170.000.195-0.0090.000
call3.000.001.350.034.5998.000.000.157-0.0110.000
call4.000.000.100.095.4332110.000.142-0.0120.000
call5.000.000.250.006.0410.000.000.133-0.0130.000
put1.000.000.100.052.3912020.00-0.303-0.0080.001
put2.000.004.701.400.00012.000.00-0.805-0.0090.000
put3.000.202.450.0012.8850.000.00-0.843-0.0110.000
put4.002.205.400.000.0000.000.00-0.858-0.0120.000
put5.001.506.500.000.0000.000.00-0.867-0.0120.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-308-KCurrent report2026-10-30SEC
2026-10-298-KCurrent report2026-10-29SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-09-25424B5SEC
2026-09-168-KCurrent report2026-09-16SEC
2026-08-178-KCurrent report2026-08-17SEC
2026-08-138-KCurrent report2026-08-13SEC
2026-08-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-28SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-28SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-28SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-28SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-28SEC
2026-07-284Statement of changes in beneficial ownership of securities2026-07-27SEC
2026-07-164Statement of changes in beneficial ownership of securities2026-07-15SEC
2026-07-168-KCurrent report2026-07-15SEC
2026-07-078-KCurrent report2026-07-01SEC
2026-06-308-KCurrent report2026-06-24SEC
2026-06-264Statement of changes in beneficial ownership of securities2026-06-24SEC
2026-06-263Initial statement of beneficial ownership of securities2026-06-24SEC
2026-06-254Statement of changes in beneficial ownership of securities2026-06-24SEC
2026-06-254Statement of changes in beneficial ownership of securities2026-06-24SEC
2026-06-254Statement of changes in beneficial ownership of securities2026-06-24SEC
2026-06-254Statement of changes in beneficial ownership of securities2026-06-24SEC
2026-06-164Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-048-KCurrent report2026-06-04SEC
2026-05-19SCHEDULE 13D/ASEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-138-KCurrent report2026-05-13SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-071000.00K100
2026-062.00M100
2026-052.00M100
2026-042.00M100
2026-031.68M100
2026-021.98M100
2026-013.98M200
2025-122.01M200
2025-111.98M100

Institutional holders

Manager% owned
VANGUARD CAPITAL MANAGEMENT LLC2.05%
Tanager Wealth Management LLP0.67%
GEODE CAPITAL MANAGEMENT, LLC0.57%
TUDOR INVESTMENT CORP ET AL0.48%
VANGUARD FIDUCIARY TRUST CO0.38%
COMMONWEALTH EQUITY SERVICES, LLC0.36%
BlackRock, Inc.0.35%
MONETARY MANAGEMENT GROUP INC0.22%
STATE STREET CORP0.18%
NORTHERN TRUST CORP0.14%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND1.29%
VANGUARD EXTENDED MARKET INDEX FUND0.75%
Fidelity Extended Market Index Fund0.31%
iShares Micro-Cap ETF0.16%
Fidelity Total Market Index Fund0.12%
Fidelity Series Total Market Index Fund0.09%
Fidelity Nasdaq Composite Index Fund0.04%
Schwab Total Stock Market Index Fund0.04%
VANGUARD BALANCED INDEX FUND0.02%
1290 VT Micro Cap Portfolio0.01%

OakChart. VANI. Cached 15 minutes.

Some panels did not load: ratings.